药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metacycline
Eperisone
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Eperisone.
Metacycline
Fendiline
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Fendiline.
Metacycline
Indenolol
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Indenolol.
Metacycline
Antazoline
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Antazoline.
Metacycline
Nilvadipine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Nilvadipine.
Metacycline
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Nemonoxacin.
Metacycline
Tucidinostat
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Tucidinostat.
Metacycline
Tedisamil
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Tedisamil.
Metacycline
Garenoxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Garenoxacin.
Metacycline
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Technetium Tc-99m ciprofloxacin.
Metacycline
Pracinostat
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Pracinostat.
Metacycline
Azimilide
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Azimilide.
Metacycline
Fluspirilene
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Fluspirilene.
Metacycline
Prenylamine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Prenylamine.
Metacycline
Terlipressin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Terlipressin.
Metacycline
Aceprometazine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Aceprometazine.
Metacycline
Probucol
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Probucol.
Metacycline
Gemifloxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Gemifloxacin.
Metacycline
Papaverine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Papaverine.
Metacycline
Dimenhydrinate
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Dimenhydrinate.